**Company Description**
Gerresheimer Querétaro S.A. in Mexico produces primary glass packaging for pharmaceutical use. Type I glass is produced in clear and amber glass. The broad product range includes ampoules, serum vials, screw thread vials, ready-to-fill syringes and cartridges.
- Collect cost information and maintain an expense database
- Build data accumulation systems.
- Determine fixed costs (e.g., salaries, rent, and insurance) P
- lan and record variable costs (e.g., raw material purchases and operating costs)
- Review standard and actual costs for inaccuracies.
- Prepare budget reports (for the company and for each department).
- Analyze and report profit margins Prepare cost forecasts (monthly, quarterly, and annual) Assist with month-end and year-end closing Identify and recommend cost-effective solutions
**Qualifications**
- Proven work experience as a cost accountant, cost analyst, bookkeeper or similar position Extensive knowledge of accounting procedures.
- In-depth understanding of generally accepted accounting principles (GAAP)
- Experience with accounting software Computer skills, MS Excel in particular
- Excellent analytical skills with attention to detail.
- Experience with accounting software Computer literacy, MS Excel in particular Excellent analytical skills with attention to detail.
- Strong time management skills Integrity, with ability to handle confidential information.
- Advanced English
- Bachelor's degree in Accounting, Finance or relevant study.
**Additional Information**
Gerresheimer is the innovative system and solution provider and global partner for the pharma and biotech industry. The company offers a comprehensive portfolio of pharmaceutical containment solutions, drug delivery systems and medical devices as well as solutions for the health and cosmetics industry. The product range includes digital solutions for therapy support, medication pumps, syringes, pens, auto-injectors and inhalers as well as vials, ampoules, tablet containers, dropper bottles, other bottles and more. Gerresheimer ensures the safe delivery and administration of drugs to the patient. With 36 production sites in 16 countries in Europe, America and Asia, Gerresheimer has a global presence and produces locally for the regional markets. With over 11,000 employees, the company generated revenues of around €1.82bn in 2022. Gerresheimer AG is listed in the MDAX on the Frankfurt Stock Exchange (ISIN: DE000A0LD6E6).
LinkeInd : Gerresheimer